Axon Enterprise (AXON)
(Delayed Data from NSDQ)
$316.76 USD
+8.31 (2.69%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $314.97 -1.79 (-0.57%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$316.76 USD
+8.31 (2.69%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $314.97 -1.79 (-0.57%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Zacks News
Rexahn Pharmaceuticals (RNN) in Focus: Stock Moves 6.1% Higher
by Zacks Equity Research
Rexahn Pharmaceuticals (RNN) was a big mover last session, as the company saw its shares rise more than 6% on the day.
Company News For Sep 27, 2017
by Zacks Equity Research
Companies in the news are: RHT,DRI,CCL,AXON
Axovant Sciences (AXON) Stock Crashed Over 70%: Here's Why
by Madeleine Johnson
On Tuesday, shares of biopharmaceutical company Axovant Sciences Ltd. (AXON) have crashed, and the stock is currently down over 70% to $6.72 per share in late-morning trading after it said that its experimental Alzheimer's drug failed a key late-stage trial.
Options Traders Expect Huge Moves in Axovant Sciences (AXON) Stock
by Zacks Equity Research
Surging implied volatility makes Axovant Sciences (AXON) Stock lucrative to the option traders.
Axovant Sciences Ltd. (AXON) Jumps: Stock Rises 7.2%
by Zacks Equity Research
Axovant Sciences Ltd. (AXON) was a big mover last session, as the company saw its shares rise over 7% on the day.
Are Options Traders Betting on a Big Move in Axovant Sciences (AXON) Stock?
by Zacks Equity Research
High level of implied volatility makes Axovant Sciences (AXON) Stock lucrative to the option traders.
Options Traders Expect Huge Moves in Axovant Sciences (AXON) Stock
by Zacks Equity Research
Axovant Sciences (AXON) needs Investors to pay close attention to the stock based on moves in the options market lately.
Implied Volatility Surging for Axovant Sciences (AXON) Stock Options
by Zacks Equity Research
Axovant Sciences (AXON) warrants investors' attention based on moves in the options market lately.
Implied Volatility Surging for Axovant Sciences (AXON) Stock Options
by Zacks Equity Research
Investors in Axovant Sciences Ltd. (AXON) need to pay close attention to the stock based on moves in the options market lately.
Arena Pharmaceuticals (ARNA) Posts Q1 Loss, Revenues Down
by Zacks Equity Research
Arena Pharmaceuticals, Inc. (ARNA) reported loss of 9 cents per share in the first quarter of 2017, same as in the year-ago period but wider than the Zacks Consensus Estimate of a loss of 8 cents.
Implied Volatility Surging for Axovant Sciences (AXON) Stock Options
by Zacks Equity Research
Axovant Sciences (AXON) warrants investors' attention based on moves in the options market lately.
Axovant Sciences (AXON) Shows Strength: Stock Jumps 9.2%
by Debasmita Banerjee
Axovant Sciences Ltd. (AXON) shares rose a little above 9% in the last trading session.
Is the Options Market Predicting a Spike in Axovant Sciences (AXON) Stock?
by Zacks Equity Research
Options traders are pricing in a big move for Axovant Sciences (AXON) shares as it has huge implied volatility.
The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences
Implied Volatility Surging for Axovant Sciences (AXON) Stock Options
by Zacks Equity Research
Axovant Sciences (AXON) warrants investors' attention based on moves in the options market lately.